Compounds > hyaluronoglucosaminidase
Page last updated: 2024-08-22

hyaluronoglucosaminidase and Infusion Site Adverse Event

hyaluronoglucosaminidase has been researched along with Infusion Site Adverse Event in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Al-Niaimi, F; Ali, FR; Searle, T1
Bass, LM; Fitzgerald, R; Goldberg, DJ; Graivier, MH; Lemperle, G; Lorenc, ZP1

Other Studies

2 other study(ies) available for hyaluronoglucosaminidase and Infusion Site Adverse Event

ArticleYear
Hyaluronidase in Dermatology: Uses Beyond Hyaluronic Acid Fillers.
    Journal of drugs in dermatology : JDD, 2020, 10-01, Volume: 19, Issue:10

    Topics: Administration, Cutaneous; Cosmetic Techniques; Dermatology; Drug Delivery Systems; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injection Site Reaction; Injections, Subcutaneous; Off-Label Use; Skin Absorption; Skin Diseases

2020
Differentiating Nonpermanent Injectable Fillers: Prevention and Treatment of Filler Complications.
    Aesthetic surgery journal, 2018, Apr-06, Volume: 38, Issue:suppl_1

    Topics: Adult; Anti-Inflammatory Agents; Cosmetic Techniques; Dermal Fillers; Female; Granuloma, Foreign-Body; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hyperbaric Oxygenation; Incidence; Injection Site Reaction; Injections, Subcutaneous; Male; Massage; Middle Aged; Practice Guidelines as Topic; Time Factors; Treatment Outcome

2018